Should a statin be given to all hypertensive patients? by Harry Struijker-Boudier

Subjects: Get full text

A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk by Manfrin A, Trimarco V, Manzi MV, Rozza F, Izzo R

Subjects: Get full text

Comparative Effectiveness of Personalized Lifestyle Management Strategies for Cardiovascular Disease Risk Reduction by Paula Chu, Ankur Pandya, Joshua A. Salomon, Sue J. Goldie, M. G. Myriam Hunink

Subjects: “…cardiovascular risk reduction…”
Get full text

Etiology and Management of Dyslipidemia in Patients With Cancer by Mikhail de Jesus, Turab Mohammed, Meghana Singh, John G. Tiu, Agnes S. Kim

Subjects: Get full text

ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction by Brian Pinto, Uday Jadhav, Pankaj Singhai, S. Sadhanandham, Nishita Shah

Subjects: Get full text

Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: decreased CIMT, reduced plasma lipid levels, and decreased blood pressure by Yacov Fogelman, Diana Gaitini, Eli Carmeli

Subjects: Get full text

Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter? by Alexander Tenenbaum, Enrique Z. Fisman

Subjects: Get full text

Postpartum Interventions to Reduce Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: A Systematic Review by Nicla A. Lui, Gajana Jeyaram, Amanda Henry, Amanda Henry, Amanda Henry

Subjects: “…cardiovascular risk reduction…”
Get full text

Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction by Geeta Sikand, MA, RDN, FAND, CDE, CLS, FNLA, Tracy Severson, BS, RDN

Subjects: Get full text

Deprescribing in type 2 diabetes and cardiovascular disease: Recommendations for safe and effective initiation of glucagon-like peptide-1 receptor agonists in patients on insulin t... by Elizabeth Van Dril, Margaret Allison, Christie Schumacher

Subjects: Get full text

Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States by Jordan B. King, Swati Sakhuja, Catherine G. Derington, Paul Kolm, Jennifer S. Herrick, Ransmond O. Berchie, Jincheng Shen, Tom Greene, Gabriel S. Tajeu, George Howard, Emily B. Levitan, Paul Muntner, Monika M. Safford, Jian Ying, William S. Weintraub, Andrew E. Moran, Adam P. Bress, Brandon K. Bellows

Subjects: Get full text